| Trial ID: | L0884 |
| Source ID: | JPRN-UMIN000016306
|
| Associated Drug: |
Glimepiride
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 diabetes
|
| Interventions: |
Dapagliflozin 5 mg/day <br>Glimepiride 0.5 mg/day
|
| Outcome Measures: |
Liver attenuation indexVisceral fat area
|
| Sponsor/Collaborators: |
Tokyo Medical and Dental University
|
| Gender: |
All
|
| Age: |
20years-oldNot applicable
|
| Phases: |
Not selected
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Cross-over Randomized
|
| Start Date: |
27/01/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018927
|
